Quest Diagnostics Incorporated ( DGX) - Key Metrics
DGX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $25.28 | $2.21 | $4.19 | $2.77 |
| 2025Q3 | $25.14 | $2.19 | $5.03 | $3.74 |
| 2025Q2 | $24.65 | $2.52 | $4.86 | $3.89 |
| 2025Q1 | $23.89 | $1.98 | $2.83 | $1.77 |
DGX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 36.73% | 19.65 |
| 2025Q3 | 36.33% | 21.78 |
| 2025Q2 | 31.91% | 17.84 |
| 2025Q1 | 38.18% | 21.34 |
DGX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.76% | ? |
| 2025Q4 | 1.59% | 0.47% |
| 2025Q3 | 1.96% | 0.42% |
| 2025Q2 | 2.17% | 0.45% |
| 2025Q1 | 1.05% | 0.45% |
DGX
List: Contenders
Price: $196.12
Dividend Yield: 1.69%
Forward Dividend Yield: 1.75%
Payout Ratio: 40.49%
Dividend Per Share: 3.44 USD
Earnings Per Share: 9.00 USD
P/E Ratio: 21.28
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.3 million
Ebitda: 346.0 millionMarket Capitalization: 21.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 23
DGR3: 8.27%
DGR5: 8.27%
DGR10: 9.60%
DGR20: 13.64%